MeiraGTx Holdings (MGTX) EBT Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) reported EBT Margin of 31.44% for Q4 2025, up 18978.0% on a YoY basis from N/an in Q4 2024, and up 100.26% quarter-over-quarter from 11940.24% in Q3 2025.
MeiraGTx Holdings (MGTX) EBT Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported EBT Margin for 7 years, with the latest figure at 31.44% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 18978.0% year-over-year to 31.44%; the trailing twelve-month figure through Dec 2025 stood at 115.36% (up 40551.0% YoY), and the FY2025 full-year result was 142.95%, up 37792.0% from the prior year.
- EBT Margin for Q4 2025 stood at 31.44%, up from 11940.24% in the prior quarter.
- The five-year high for EBT Margin was 822.96% in Q4 2022, with the low at 17140.43% in Q2 2024.
- Historically, EBT Margin has averaged 2339.9% across 5 years, with a median of 506.89% in 2022.
- Annual changes were most pronounced in 2024 — EBT Margin tumbled 1625102 bps — and 2025, when it jumped 1585571 bps.
- MeiraGTx Holdings' EBT Margin stood at 37.0% in 2021, then jumped by 2324 bps to 822.96% in 2022, then plunged by 378 bps to 2286.96% in 2023, then surged by 93 bps to 158.34% in 2024, then surged by 120 bps to 31.44% in 2025.
- The last three EBT Margin figures came in at 31.44% (Q4 2025), 11940.24% (Q3 2025), and 1284.72% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 31.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.44% |
| Sep 30, 2025 | -11,940.24% |
| Jun 30, 2025 | -1,284.72% |
| Dec 31, 2024 | -158.34% |
| Sep 30, 2024 | -386.88% |
| Jun 30, 2024 | -17,140.43% |
| Mar 31, 2024 | -7,019.37% |
| Dec 31, 2023 | -2,286.96% |
| Sep 30, 2023 | -698.02% |
| Jun 30, 2023 | -889.41% |
| Mar 31, 2023 | -1,028.04% |
| Dec 31, 2022 | 822.96% |
| Sep 30, 2022 | -506.89% |
| Jun 30, 2022 | -221.20% |
| Mar 31, 2022 | -511.18% |
| Dec 31, 2021 | -37.00% |
| Sep 30, 2021 | -324.96% |
| Jun 30, 2021 | -400.06% |
| Mar 31, 2021 | -478.82% |
| Dec 31, 2020 | -346.36% |